Intrinsic Value

Xenon Pharmaceuticals Inc. (XENE)

$43

+0.34 (+0.80%)

Enterprise Value -34,473.03
Net Debt -137.74
Equity Value -34,335.29
Shares Outstanding 66.89
Equity Value Per Share -513.32



Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt